EVAX
Evaxion AS
NASDAQ · Healthcare · Biotechnology · DK
$3.27
+1.55%Institutional positioning
13F filings over the trailing two quarters
New 10Increased 4Reduced 8Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Merck & Co., Inc. | New Position | 1,214,126 | Aug 7, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 74,698 | May 15, 2026 |
| Ikarian Capital, LLC | Unchanged | 74,698 | Aug 14, 2026 |
| RATHBONES GROUP PLC | New Position | 45,723 | Jun 9, 2026 |
| Rathbones Group PLC | Unchanged | 45,723 | Jul 23, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 39,225 | May 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 36,584 | Sep 2, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 33,800 | Aug 13, 2026 |
| ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | New Position | 30,000 | May 6, 2026 |
| Annis Gardner Whiting Capital Advisors, LLC | Unchanged | 30,000 | Aug 10, 2026 |
| J. Safra Sarasin Holding AG | New Position | 22,896 | Jul 31, 2026 |
| XTX TOPCO LTD | New Position | 22,053 | May 15, 2026 |
| RHUMBLINE ADVISERS | Increased | 21,849 | Aug 12, 2026 |
| RHUMBLINE ADVISERS | Increased | 21,659 | May 12, 2026 |
| JANE STREET GROUP, LLC | New Position | 20,581 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings